CRISP: A phase Ib of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies (Study ITCC 053)

  • Fenwick, Nicola (Co-Investigator)
  • Kearns, Pamela (Principal Investigator)
  • Seaford, Emma (Co-Investigator)

Project Details

Short titleCRISP: A phase Ib of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies (Study ITCC 053)
StatusActive
Effective start/end date1/04/18 → 31/10/24

Funding

  • Erasmus Univesitair Medisch Centrum
  • Cancer Research Uk